Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-20-011752

EVP/Chief Scientific Officer sold 20,000 shares at $40.02 ($800,400)

  • EVP/Chief Scientific Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Albright Charles · EVP/Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-07 Exercise or conversion : show line 1 in the form +20,000 $16.51 $330,200 44,907 D
2020-12-07 Sale : show line 2 in the form −20,000 $40.02 $800,400 24,907 D
Open-market sales · 20,000 sh · avg $40.02 · $800,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-07 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −20,000 165,000 D
Loading xslF345X03/edgar.xml…